◆英語タイトル：Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review
◆商品コード：SWOT20MY1671
◆発行会社（調査会社）：
GlobalData
◆発行日：2020年4月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スウェーデン
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Active Biotech AB (ACTI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Active Biotech AB (Active Biotech) is a biotechnology company that focuses on the development of therapeutics in the field of cancer, eye disorders and inflammatory/neurodegenerative diseases. The company’s pipeline products in development include Anyara or Naptumomab Estafenatox (naptumomab) for the treatment of solid tumors; tasquinimod for multiple myeloma; and laquinimod for both wetAMD and Uveitis. It has partnership with NeoTX Therapeutics Ltd and with the Perelman School of Medicine, University of Pennsylvania. Active Biotech is headquartered in Lund, Sweden.
Active Biotech AB Key Recent Developments
Apr 23,2020 Active Biotech interim report January – March 2020
Feb 05,2020 Active Biotech announces new direction
Aug 08,2019 Active Biotech: Interim report January – June 2019
May 02,2019 The Election Committee of Active Biotech proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Active Biotech AB – Key Facts
Active Biotech AB – Key Employees
Active Biotech AB – Key Employee Biographies
Active Biotech AB – Major Products and Services
Active Biotech AB – History
Active Biotech AB – Company Statement
Active Biotech AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Active Biotech AB – Business Description
Active Biotech AB – SWOT Analysis
SWOT Analysis – Overview
Active Biotech AB – Strengths
Active Biotech AB – Weaknesses
Active Biotech AB – Opportunities
Active Biotech AB – Threats
Active Biotech AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Active Biotech AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Active Biotech interim report January – March 2020
Feb 05, 2020: Active Biotech announces new direction
Aug 08, 2019: Active Biotech: Interim report January – June 2019
May 02, 2019: The Election Committee of Active Biotech proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board
Apr 25, 2019: Active Biotech – Interim report January – March 2019
Feb 14, 2019: Active Biotech year-end report January – December 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Active Biotech AB, Key Facts
Active Biotech AB, Key Employees
Active Biotech AB, Key Employee Biographies
Active Biotech AB, Major Products and Services
Active Biotech AB, History
Active Biotech AB, Other Locations
Active Biotech AB, Subsidiaries
Active Biotech AB, Key Competitors
Active Biotech AB, Ratios based on current share price
Active Biotech AB, Annual Ratios
Active Biotech AB, Annual Ratios (Cont...1)
Active Biotech AB, Interim Ratios
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Active Biotech AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Active Biotech AB, Performance Chart (2015 - 2019)
Active Biotech AB, Ratio Charts
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
